1.
Honigberg MC, Economy KE, Pabón MA, et al. Coronary Microvascular Function Following Severe Preeclampsia. Hypertension (Dallas, Tex. : 1979). 2024. doi:10.1161/HYPERTENSIONAHA.124.22905.
1.
Shetty NS, Pampana A, Patel N, et al. Sex Differences in the Association of Multiethnic Genome-Wide Blood Pressure Polygenic Risk Score With Population-Level Systolic Blood Pressure Trajectories. Circulation. Genomic and precision medicine. 2024:e004515. doi:10.1161/CIRCGEN.123.004515.
1.
Aaramaa H-K, Mars N, Helminen M, et al. Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases. Seminars in arthritis and rheumatism. 2024;65:152382. doi:10.1016/j.semarthrit.2024.152382.
1.
Carrasquilla GD, Ängquist L, Sørensen TIA, Kilpeläinen TO, Loos RJF. Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease. Diabetologia. 2023. doi:10.1007/s00125-023-06058-4.
1.
Goodman MO, Dashti HS, Lane JM, et al. Causal Association Between Subtypes of Excessive Daytime Sleepiness and Risk of Cardiovascular Diseases. Journal of the American Heart Association. 2023;12(24):e030568. doi:10.1161/JAHA.122.030568.
1.
Cho SMJ, Lee H, Koyama S, et al. Cumulative Diastolic Blood Pressure Burden in Normal Systolic Blood Pressure and Cardiovascular Disease. Hypertension (Dallas, Tex. : 1979). 2024;81(2):273-281. doi:10.1161/HYPERTENSIONAHA.123.22160.
1.
Salazar-Martín AG, Kalluri AS, Villanueva MA, et al. Single-Cell RNA Sequencing Reveals Cellular Adaptation of Human Aortic Endothelial Cells to Antiproliferative Therapies Is Modulated by Flow-Induced Shear Stress. Arteriosclerosis, thrombosis, and vascular biology. 2023. doi:10.1161/ATVBAHA.123.319283.
1.
Guasch-Ferré M, Ruiz-Canela M, Li J, et al. Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk. J Clin Endocrinol Metab. 2019;104(5):1508-1519. doi:10.1210/jc.2018-01000.
1.
Wang DD, Zheng Y, Toledo E, et al. Lipid metabolic networks, Mediterranean diet and cardiovascular disease in the PREDIMED trial. Int J Epidemiol. 2018;47(6):1830-1845. doi:10.1093/ije/dyy198.
1.
Razquin C, Toledo E, Clish CB, et al. Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial. Diabetes Care. 2018;41(12):2617-2624. doi:10.2337/dc18-0840.